[144] ESAB Corporation SEC Filing

Rhea-AI Filing Summary

Form 144 notice from ESAB Corporation (ticker: ESAB) shows a proposed sale of 2,100 common shares through Fidelity Brokerage Services (NYSE) with an aggregate market value of $240,093 and approximate sale date of 09/04/2025. The filer reports recent acquisitions of the same class via restricted stock vesting on 01/10/2025 (1,551 shares), 02/22/2025 (218 shares) and 03/08/2025 (331 shares), all paid as compensation. The filing also discloses a sale of 2,369 shares on 08/22/2025 generating $277,466.45. The filer certifies no undisclosed material adverse information and includes the standard Rule 144 representations.

Positive

• Transparent disclosure of proposed sale (2,100 shares) including broker, exchange and aggregate market value
• Acquisition details provided showing shares were received via restricted stock vesting and paid as compensation
• Prior sale disclosed (2,369 shares on 08/22/2025 for $277,466.45), supporting transaction history transparency
• Filer includes Rule 144 representations affirming no undisclosed material adverse information

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider notice of proposed sale; size appears modest relative to total outstanding shares.

The filing is a standard Form 144 notifying the market of an insider's intent to sell 2,100 common shares on the NYSE through Fidelity, valued at $240,093. The shares to be sold were recently acquired through restricted stock vesting and were paid as compensation, which is disclosed in the acquisition table. The filing also reports a prior sale of 2,369 shares generating $277,466.45. For investors, this is a transparency event consistent with Rule 144 and does not by itself provide new operational or financial information about the issuer.

Compliance/Risk Analyst

TL;DR: Filing meets Rule 144 disclosure requirements and includes the required representations and vesting details.

The notice includes required broker identification, share counts, acquisition dates, and compensation payment characterization for vested restricted stock, which supports compliance with resale conditions under Rule 144. The signer affirms absence of undisclosed material adverse information and references trading-plan compliance language. No regulatory exceptions or deficient disclosures are evident within the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2100	240093.00	60698710	09/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/10/2025	Restricted Stock Vesting	Issuer			1551	01/10/2025	Compensation
Common	02/22/2025	Restricted Stock Vesting	Issuer			218	02/22/2025	Compensation
Common	03/08/2025	Restricted Stock Vesting	Issuer			331	03/08/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vusumuzi A. Mlingo 909 Rose Avenue 8th Floor North Bethesda MD 20852	Common	08/22/2025	2369	277466.45

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by ESAB (ESAB) disclose?

The notice discloses a proposed sale of 2,100 common shares via Fidelity on the NYSE with an aggregate market value of $240,093 and an approximate sale date of 09/04/2025.

How were the shares to be sold by the filer acquired?

The filing shows the shares were acquired through restricted stock vesting on 01/10/2025 (1,551 shares), 02/22/2025 (218 shares) and 03/08/2025 (331 shares) and paid as compensation.

Did the filer report any recent sales of the issuer's stock?

Yes. The filer reported selling 2,369 shares on 08/22/2025 for gross proceeds of $277,466.45.

Which broker and exchange are identified for the proposed sale?

The broker is Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI) and the transaction is listed for the NYSE.

Does the filer assert any undisclosed material information about ESAB?

By signing the form the filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.